Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 5,040
Out of 5,044 analysts
16
Total ratings
8.33%
Success rate
-41.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Life Sciences | Initiates: Buy | $18 | $5.96 | +202.01% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $22.62 | -24.85% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $6.55 | +419.08% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $133.51 | -28.84% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $2.38 | -15.97% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $330 | $4.23 | +7,701.42% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $1.42 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $5.14 | +522.57% | 4 | Dec 16, 2020 |
Atai Life Sciences
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $5.96
Upside: +202.01%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $22.62
Upside: -24.85%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $6.55
Upside: +419.08%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $133.51
Upside: -28.84%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $2.38
Upside: -15.97%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $330
Current: $4.23
Upside: +7,701.42%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.42
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $5.14
Upside: +522.57%